Claritev Corporation (CTEV) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Claritev Corporation stock (CTEV) is currently trading at $15.35. Claritev Corporation PS ratio (Price-to-Sales) is 0.26. Analyst consensus price target for CTEV is $42.75. WallStSmart rates CTEV as Sell.
- CTEV PE ratio analysis and historical PE chart
- CTEV PS ratio (Price-to-Sales) history and trend
- CTEV intrinsic value — DCF, Graham Number, EPV models
- CTEV stock price prediction 2025 2026 2027 2028 2029 2030
- CTEV fair value vs current price
- CTEV insider transactions and insider buying
- Is CTEV undervalued or overvalued?
- Claritev Corporation financial analysis — revenue, earnings, cash flow
- CTEV Piotroski F-Score and Altman Z-Score
- CTEV analyst price target and Smart Rating
Claritev Corporation
📊 No data available
Try selecting a different time range
Smart Analysis
Claritev Corporation (CTEV) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, institutional own.. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
Claritev Corporation (CTEV) Key Strengths (2)
Paying less than $1 for every $1 of annual revenue
93.91% of shares held by major funds and institutions
Supporting Valuation Data
Claritev Corporation (CTEV) Areas to Watch (6)
Company is destroying shareholder value
Company is losing money with a negative profit margin
Very thin margins with limited operational efficiency
Very expensive at 43.9x book value
Micro-cap company with very limited liquidity and high volatility
Modest revenue growth at 6.20%
Claritev Corporation (CTEV) Detailed Analysis Report
Overall Assessment
This company scores 31/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 2 register as strengths (avg 10.0/10) while 6 fall into concern territory (avg 1.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Institutional Own.. Valuation metrics including Price/Sales (0.26) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Profit Margin, Operating Margin. Some valuation metrics including Price/Book (43.86) suggest expensive pricing. Growth concerns include Revenue Growth at 6.20%, which may limit upside. Profitability pressure is visible in Return on Equity at -646.00%, Operating Margin at 9.77%, Profit Margin at -29.40%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -646.00% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 6.20% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Profit Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
CTEV Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
CTEV's Price-to-Sales ratio of 0.26x trades at a 27% premium to its historical average of 0.2x (76th percentile). The current valuation is 79% below its historical high of 1.22x set in Aug 2025, and Infinity% above its historical low of 0x in Aug 2024. Over the past 12 months, the PS ratio has compressed from ~0.4x as trailing revenue scaled faster than the stock price.
Compare CTEV with Competitors
Top HEALTH INFORMATION SERVICES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Claritev Corporation (CTEV) · HEALTHCARE › HEALTH INFORMATION SERVICES
The Big Picture
Claritev Corporation is in a turnaround phase, with management focused on restoring profitability. Revenue reached 965M with 6% growth year-over-year. The company is currently unprofitable, posting a -29.4% profit margin.
Key Findings
Generating 36M in free cash flow and 66M in operating cash flow. Earnings are translating into actual cash generation.
Debt-to-equity ratio of -45.69 indicates a conservative balance sheet with 51M in cash.
The company is unprofitable with a -29.4% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Debt management: total debt of 4.7B is significantly higher than cash (51M). Monitor refinancing risk.
Sector dynamics: monitor HEALTH INFORMATION SERVICES industry trends, competitive moves, and regulatory changes that could impact Claritev Corporation.
Bottom Line
Claritev Corporation is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 8:23:09 AM
About Claritev Corporation(CTEV)
NYSE
HEALTHCARE
HEALTH INFORMATION SERVICES
USA
Claritev Corporation, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company is headquartered in New York, New York.